Neximmune Inc. played its cards close to the vest after disclosing its acquisition a year ago by the Barer & Son Capital-led syndicate that included Sol Barer, chairman of Teva Pharmaceutical Industries Ltd. and former chairman and CEO of Celgene Corp., Joshua Barer, managing director of Sunflower Life Sciences, and William Hawkins, former chairman and CEO of Medtronic plc.